title: Haemophagocytic syndrome in Plasmodium falciparum malaria.
authors.forename: I
authors.initials: I
authors.lastname: Sermet-Gaudelus
authors.forename: V
authors.initials: V
authors.lastname: Abadie
authors.forename: F
authors.initials: F
authors.lastname: Stambouli
authors.forename: C
authors.initials: C
authors.lastname: Hennequin
authors.forename: G
authors.initials: G
authors.lastname: Lenoir
authors.forename: D
authors.initials: D
authors.lastname: Gendrel
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D002675:Child, Preschool; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016778:Malaria, Falciparum / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D011803:Quinine; D011241:Prednisone